First generic of new Alzheimer‘s treatment: Rivastigmine transdermal patch...

On September 25, NMPA released information on the delivery of drug certification documents, and the Rivastigmine transdermal patch of Beijing Tide Pharmaceutical Co. Ltd, a subsidiary of C...

See More

Ziprasidone mesylate - the first antipsychotic drug to be evaluated...

Ziprasidone mesylate is a new type of atypical broad-spectrum antipsychotic drug for the treatment of schizophrenia. Ziprasidone is a 5-hydroxytryptamine and dopamine receptor antagonist, especially...

See More

Ocumension‘s Anti-Allergy Eye Drug Approved for Marketing in China...

According to the official website of NMPA, Cetirizine Hydrochloride Eye Drops from Suzhou Ocumension Biotechnology Co. It is used for the treatment of itchy eyes associated with allergi...

See More

National Medical Products Administration : Multiple ways to promote the dev...

The National Information Office of China held a series of press conferences on the theme of "Promoting high-quality Development" on September 13.At the meeting, Huang Guo, deputy director o...

See More

Jioncare‘s marketing application for anti-flu drug TG-1000 capsules accepte...

Influenza, a contagious respiratory disease caused by influenza viruses, is currently one of the world‘s most serious public health challenges. Seasonal influenza occurs frequently each year. The ...

See More

Pfizer‘s new anti-cancer drug axitinib declared for new indications in China...

On August 16, the official website of the Center For Drug Evaluation,NMPA announced that Pfizer‘s application for the listing of axitinib tablets for a new indication was accepted,。...

See More

Poly Pharm Receives U.S. Marketing Approval for New Specification of B...

Recently, FDA marketing authorization was granted for additional sizes of benzenesulfonium atracurium injection: 10mg/5ml and 200mg/20ml. Previously, Puli Pharma‘s benzenesulfonium atracurium ...

See More

Simelglutide Adds New Indication

Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), which has been approved for the treatment of type 2 diabetes mellitus and obesity in several countries and region...

See More

Heat anti-Parkinson’s Disease——Carbidopa and LevodopaCR Tablets the f...

Recently,China Drug Administration (CDA)publicised the SJZ NO.4 Pharmaceutical approval certificate delivery information, CarbidopaandLevodopaCRTablets approved for listing, deemed t...

See More

Technical Guidelines for Clinical Trials of Drugs for Chronic Hepatitis D...

Technical Guidelines for Clinical Trials of Drugs for Chronic Hepatitis D Virus Infection

See More

Difference between Ornidazole, Levonidazole, and Levonidazole Phosphate Di...

Ornidazole, Levonidazole, are both approved for the treatment of anaerobic infections and protozoal infections. The structure of Ornidazole contains a chiral carbon atom with a hydroxyl group, whi...

See More

Local firms accelerate in oncology track

In recent years, the development of ablation technology in the field of oncology interventional therapy has advanced by leaps and bounds, opening up new possibilities for tumor treatment.According t...

See More

Why is there no vaccine for Mycoplasma pneumoniae? How long will it take to d...

However, the urgent clinical needs, seemingly huge market, not only the country, even the world seems to have no "mycoplasma pneumonia" pipeline exposure....

See More

New Coronavirus Infection Treatment Atetevir Tablets/Ritonavir Tablets C...

On November 24th, the State Drug Administration conditionally approved the official listing of Atetevir Tablets/Ritonavir Tablets Combination Package (trade name: Taizhongding®), a Class...

See More

China Drug Administration (CDA) Releases New Version of "Principles an...

On March 29, the website of China‘s State Drug Administration (SDA) issued a notice on the issuance of principles and procedures for exploratory studies on drug sampling, while the Notice o...

See More

Update to living WHO guideline on drugs for covid-19...

The World Health Organization (WHO) has released the ninth update of their living guideline on medications for the treatment of COVID-19 infection (A living WHO guideline on drugs for ...

See More